Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.

Wareham DW, Momin MHFA, Phee LM, Hornsey M, Standing JF.

J Antimicrob Chemother. 2019 Oct 16. pii: dkz420. doi: 10.1093/jac/dkz420. [Epub ahead of print]

PMID:
31617905
2.

A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam.

Abdul Momin MHF, Liakopoulos A, Bean DC, Phee LM, Wareham DW.

J Antimicrob Chemother. 2019 Nov 1;74(11):3392-3394. doi: 10.1093/jac/dkz352. No abstract available.

PMID:
31504534
3.

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii.

Phee LM, Kloprogge F, Morris R, Barrett J, Wareham DW, Standing JF.

J Antimicrob Chemother. 2019 Apr 1;74(4):961-969. doi: 10.1093/jac/dky524.

4.

Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices.

Wareham DW, Phee LM, Abdul Momin MHF.

J Antimicrob Chemother. 2018 Jul 1;73(7):1997-1998. doi: 10.1093/jac/dky095. No abstract available.

PMID:
29579199
5.
6.

Optimal detection of carbapenemase-producing Enterobacteriaceae from rectal samples: a role for enrichment?

Ciesielczuk H, Phee LM, Dolphin H, Wilks M, Cherian BP, Wareham DW.

J Hosp Infect. 2018 Mar;98(3):270-274. doi: 10.1016/j.jhin.2017.10.012. Epub 2017 Oct 23.

PMID:
29074053
7.

CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens.

Abdul Momin MHF, Bean DC, Hendriksen RS, Haenni M, Phee LM, Wareham DW.

J Med Microbiol. 2017 Nov;66(11):1554-1561. doi: 10.1099/jmm.0.000602. Epub 2017 Oct 6.

PMID:
28984232
8.

Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam.

Abdul Momin MHF, Liakopoulos A, Phee LM, Wareham DW.

J Glob Antimicrob Resist. 2017 Jun;9:96-99. doi: 10.1016/j.jgar.2017.02.008. Epub 2017 Apr 27.

PMID:
28458051
9.

Rifaximin combined with polymyxins: A potential regimen for selective decontamination of multidrug-resistant bacteria in the digestive tract?

Betts JW, Phee LM, Wareham DW.

J Glob Antimicrob Resist. 2016 Mar;4:11-15. doi: 10.1016/j.jgar.2015.11.008. Epub 2015 Dec 23.

PMID:
27436386
10.

Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.

Oikonomou O, Liakopoulos A, Phee LM, Betts J, Mevius D, Wareham DW.

Microb Drug Resist. 2016 Jul;22(5):379-86. doi: 10.1089/mdr.2015.0215. Epub 2016 Jan 26.

PMID:
27380549
11.

Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae.

Wareham DW, Shah R, Betts JW, Phee LM, Momin MH.

J Clin Microbiol. 2016 Feb;54(2):471-3. doi: 10.1128/JCM.02900-15. Epub 2015 Nov 25.

12.

In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.

Betts JW, Sharili AS, Phee LM, Wareham DW.

J Nat Prod. 2015 Aug 28;78(8):2145-8. doi: 10.1021/acs.jnatprod.5b00471. Epub 2015 Aug 12.

PMID:
26267658
13.

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.

Phee LM, Betts JW, Bharathan B, Wareham DW.

Antimicrob Agents Chemother. 2015 Aug;59(8):4544-50. doi: 10.1128/AAC.00753-15. Epub 2015 May 18.

14.

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.

Makena A, Brem J, Pfeffer I, Geffen RE, Wilkins SE, Tarhonskaya H, Flashman E, Phee LM, Wareham DW, Schofield CJ.

J Antimicrob Chemother. 2015 Feb;70(2):463-9. doi: 10.1093/jac/dku403. Epub 2014 Oct 16.

15.

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.

Betts JW, Phee LM, Woodford N, Wareham DW.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1565-72. doi: 10.1007/s10096-014-2101-3. Epub 2014 Apr 30.

PMID:
24781003
16.

In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.

Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW.

Antimicrob Agents Chemother. 2014 Jun;58(6):3541-6. doi: 10.1128/AAC.02449-14. Epub 2014 Mar 31.

Supplemental Content

Support Center